Search
for
Sort by
Research 691–720 of 1000+
- More than one way to skin . . .
- Epigenetic control of adult stem cell function
- p53‐dependent transcriptional regulation of EDA2R and its involvement in chemotherapy‐induced hair loss
- Regulation of VDR by ΔNp63α is associated with inhibition of cell invasion
- Complications of liver transplantation: A perioperative perspective
- COSMECEUTICALS: THE BIOACTIVE ELEMENTS IN NEW-AGE BEAUTY PRODUCTS
- Janus Kinase inhibitors in dermatology: a review
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes
- Rosemary bioactive phytochemicals as a strategy for the management of age related conditions
- Application and progress of induced pluripotent stem in chronic wound healing: a narrative review
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Contents list
- Transgender adolescents and acne: A cases series
- Preparing regenerative therapies for clinical application: proposals for responsible translation
- Adrenaline Infiltration in The Recipient Area During Follicular Unit Extraction Using the Implanter Technique: A Prospective Observational Study
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- LOP14
- Highlights
- 5α-reductase inhibitors impact prognosis of urothelial carcinoma
- Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study.
- Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review)
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Protein Kinase C as a Therapeutic Target
- Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Repurposing of Various Current Medicines as Radioprotective Agents
- Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation
- Imaging to study solid tumour origin and progression: lessons from research and clinical oncology
- Editorial Comment